Advertisement
Skip to Content

Clinuvel Pharmaceuticals Ltd ADR CLVLY Stock Quote

| Rating as of

PINX: CLVLY

Last close prices updated as of Feb 02, 2023, 3:57 PM EST | USD
  • Last Close 17.3
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 17.10  –  17.79
  • Year Range 9.17  –  19.98
  • Market Cap 867.0773 Mil
  • Volume / Avg 2,044.0 /  5,480.4
  • Price / Sales 19.34
  • Price / Book 9.66
  • Forward Div Yield 0.15%
  • Trailing Div Yield 0.15%

Morningstar‘s Stock Analysis CLVLY

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CLVLY

Company Profile CLVLY

Business Description

Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of genetic and vascular disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to several depigmentation disorders. Geographically, it derives a majority of its revenue from Europe and the USA.

Contact
535 Bourke Street, Level 11
Melbourne, VIC, 3000, AUS
Industry Biotechnology
Employees 16

FAQs for Clinuvel Pharmaceuticals Ltd ADR Stock

Yes. CLVLY has a forward dividend yield of 0.15%. See CLVLY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CLVLY’s market cap is 867.08 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CLVLY’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CLVLY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CLVLY’s historical performance against its industry peers and the overall market.